☰

Seokjoong Kang, Ph.D. - Publications

Affiliations: 
2003 University of California, Irvine, Irvine, CA 
Area:
Computer Science
Tree Info Similar researchers PubMed Report error

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Jeeva S, Kim KH, Shin CH, Wang BZ, Kang SM. An Update on mRNA-Based Viral Vaccines. Vaccines. 9. PMID 34579202 DOI: 10.3390/vaccines9090965  0.349
2021 Aziz AB, Zaman K, Kim DR, Park JY, Im J, Ali M, Ahmmed F, Islam MT, Khanam F, Chowdhury F, Ahmed T, Hoque M, Liu X, Pak GD, Tadesse BT, ... ... Kang S, et al. Re-evaluation of population-level protection conferred by a rotavirus vaccine using the 'fried-egg' approach in a rural setting in Bangladesh. Vaccine. PMID 34454788 DOI: 10.1016/j.vaccine.2021.08.048  0.321
2021 Kim KH, Lee YT, Park Y, Ko EJ, Jung YJ, Kim YJ, Jo EK, Kang SM. BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection. Biomedicines. 9. PMID 34063125 DOI: 10.3390/biomedicines9050516  0.458
2021 Park Y, Kim KH, Lee Y, Lee YT, Kang SM, Ko EJ. Natural killer cells contribute to enhanced respiratory disease after oil-in-water emulsion adjuvanted vaccination against respiratory syncytial virus and infection. Human Vaccines & Immunotherapeutics. 1-12. PMID 33877948 DOI: 10.1080/21645515.2021.1915039  0.388
2021 Kim KH, Bhatnagar N, Jeeva S, Oh J, Park BR, Shin CH, Wang BZ, Kang SM. Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice. Vaccines. 9. PMID 33805473 DOI: 10.3390/vaccines9040316  0.381
2021 Hwang HS, Lee YT, Kim KH, Seo HS, Yang KS, Cho H, Kang SM. Roles of the Fc Receptor γ-Chain in Inducing Protective Immune Responses after Heterologous Vaccination against Respiratory Syncytial Virus Infection. Vaccines. 9. PMID 33800349 DOI: 10.3390/vaccines9030232  0.449
2020 Jung YJ, Kim KH, Ko EJ, Lee Y, Kim MC, Lee YT, Kim CH, Jeeva S, Park BR, Kang SM. Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient mice. Vaccine. PMID 32674907 DOI: 10.1016/j.vaccine.2020.06.075  0.585
2019 Kim KH, Lee YT, Park S, Jung YJ, Lee Y, Ko EJ, Kim YJ, Li X, Kang SM. Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus. Virology. 535: 179-188. PMID 31310875 DOI: 10.1016/j.virol.2019.07.008  0.585
2019 Kwon YM, Hwang HS, Lee YT, Kim KH, Lee Y, Kim MC, Lee YN, Quan FS, Moore ML, Kang SM. Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform. Immune Network. 19: e18. PMID 31281715 DOI: 10.4110/In.2019.19.E18  0.551
2019 Lee Y, Ko EJ, Kim KH, Lee YT, Hwang HS, Kwon YM, Graham BS, Kang SM. A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus. Virology. 534: 1-13. PMID 31163351 DOI: 10.1016/J.Virol.2019.05.010  0.547
2019 Lee Y, Ko EJ, Kim KH, Lee YT, Hwang HS, Jung YJ, Jeeva S, Kwon YM, Seong BL, Kang SM. The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants. Antiviral Research. PMID 31150678 DOI: 10.1016/j.antiviral.2019.05.011  0.572
2019 Hu X, Kim KH, Lee Y, Fernandes J, Smith MR, Jung Y, Orr M, Kang SM, Jones DP, Go YM. Environmental Cadmium Enhances Lung Injury by Respiratory Syncytial Virus Infection. The American Journal of Pathology. PMID 31108100 DOI: 10.1016/J.Ajpath.2019.04.013  0.358
2019 Ko EJ, Lee Y, Lee YT, Jung YJ, Ngo VL, Kim MC, Kim KH, Wang BZ, Gewirtz AT, Kang SM. Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice. Vaccine. PMID 31101421 DOI: 10.1016/J.Vaccine.2019.05.018  0.555
2019 Kotomina T, Isakova-Sivak I, Matyushenko V, Kim KH, Lee Y, Jung YJ, Kang SM, Rudenko L. Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease. Antiviral Research. PMID 31075351 DOI: 10.1016/j.antiviral.2019.05.001  0.573
2019 Kim MC, Kim KH, Lee JW, Lee YN, Choi HJ, Jung YJ, Kim YJ, Compans RW, Prausnitz MR, Kang SM. Co-Delivery of M2e Virus-Like Particles with Influenza Split Vaccine to the Skin Using Microneedles Enhances the Efficacy of Cross Protection. Pharmaceutics. 11. PMID 31003421 DOI: 10.3390/Pharmaceutics11040188  0.57
2019 Kim MW, Jeong HY, Kang SJ, Jeong IH, Choi MJ, You YM, Im CS, Song IH, Lee TS, Lee JS, Lee A, Park YS. Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer. Theranostics. 9: 837-852. PMID 30809312 DOI: 10.7150/thno.30228  0.408
2019 Lee YT, Kim KH, Ko EJ, Kim MC, Lee YN, Hwang HS, Lee Y, Jung YJ, Kim YJ, Santos J, Perez DR, Kang SM. Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles. Virology. 529: 111-121. PMID 30685658 DOI: 10.1016/j.virol.2019.01.017  0.581
2018 Park S, Lee Y, Kwon YM, Lee YT, Kim KH, Ko EJ, Jung JH, Song M, Graham B, Prausnitz MR, Kang SM. Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge. Plos One. 13: e0205071. PMID 30365561 DOI: 10.1371/Journal.Pone.0205071  0.553
2018 Kim KH, Kwon YM, Lee YT, Kim MC, Hwang HS, Ko EJ, Lee Y, Choi HJ, Kang SM. Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus. Vaccines. 6. PMID 30241300 DOI: 10.3390/vaccines6040066  0.539
2018 Wang Y, Jung YJ, Kim KH, Kwon Y, Kim YJ, Zhang Z, Kang HS, Wang BZ, Quan FS, Kang SM. Antiviral Activity of Fermented Ginseng Extracts against a Broad Range of Influenza Viruses. Viruses. 10. PMID 30200514 DOI: 10.3390/v10090471  0.46
2018 Kim KH, Kwon YM, Lee YT, Hwang HS, Kim MC, Ko EJ, Wang BZ, Quan FS, Kang SM. Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine. Virology. 524: 172-181. PMID 30199754 DOI: 10.1016/j.virol.2018.08.019  0.584
2018 Kim YJ, Kim KH, Ko EJ, Kim MC, Lee YN, Jung YJ, Lee YT, Kwon YM, Song JM, Kang SM. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain Specific HA or Cross Protective M2e vaccination. Journal of Virology. PMID 30068650 DOI: 10.1128/JVI.00969-18  0.578
2018 Ko EJ, Lee Y, Lee YT, Kim YJ, Kim KH, Kang SM. MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine. Antiviral Research. PMID 29885376 DOI: 10.1016/j.antiviral.2018.06.004  0.573
2018 Lee YT, Ko EJ, Lee Y, Kim KH, Kim MC, Lee YN, Kang SM. Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses. Plos One. 13: e0190868. PMID 29324805 DOI: 10.1371/journal.pone.0190868  0.586
2017 Lee YT, Ko EJ, Kim KH, Hwang HS, Lee Y, Kwon YM, Kim MC, Lee YN, Jung YJ, Kang SM. Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination with Virus-Like Nanoparticles Carrying Fusion Proteins. Journal of Biomedical Nanotechnology. 13: 84-98. PMID 29302248 DOI: 10.1166/jbn.2017.2341  0.554
2017 Kim YJ, Lee YT, Kim MC, Lee YN, Kim KH, Ko EJ, Song JM, Kang SM. Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice. Frontiers in Immunology. 8: 1730. PMID 29276514 DOI: 10.3389/fimmu.2017.01730  0.583
2017 Jung YJ, Lee YT, Ngo VL, Cho YH, Ko EJ, Hong SM, Kim KH, Jang JH, Oh JS, Park MK, Kim CH, Sun J, Kang SM. Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection. Scientific Reports. 7: 17360. PMID 29234060 DOI: 10.1038/s41598-017-17487-8  0.492
2017 Park C, Cho J, Lee J, Kang SY, An JY, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Kim ST, Park SH, Park JO, Kang WK, Sohn I, et al. Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity. Oncoimmunology. 6: e1356150. PMID 29147610 DOI: 10.1080/2162402X.2017.1356150  0.55
2017 Kim MC, Lee YN, Kim YJ, Choi HJ, Kim KH, Lee YJ, Kang SM. Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate. Antiviral Research. PMID 29107058 DOI: 10.1016/j.antiviral.2017.10.018  0.512
2017 Ko EJ, Lee YT, Lee Y, Kim KH, Kang SM. Distinct Effects of Monophosphoryl Lipid A, Oligodeoxynucleotide CpG, and Combination Adjuvants on Modulating Innate and Adaptive Immune Responses to Influenza Vaccination. Immune Network. 17: 326-342. PMID 29093654 DOI: 10.4110/in.2017.17.5.326  0.316
2017 Kim YJ, Ko EJ, Kim MC, Lee YN, Kim KH, Jung YJ, Kang SM. Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection. Biochemical and Biophysical Research Communications. PMID 28887040 DOI: 10.1016/j.bbrc.2017.09.011  0.563
2017 Lee Y, Lee YT, Ko EJ, Kim KH, Hwang HS, Park S, Kwon YM, Kang SM. Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles. Human Vaccines & Immunotherapeutics. 0. PMID 28854003 DOI: 10.1080/21645515.2017.1362514  0.527
2017 Hwang HS, Lee YT, Kim KH, Ko EJ, Lee Y, Kwon YM, Kang SM. Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus. Virology. 511: 142-151. PMID 28846899 DOI: 10.1016/j.virol.2017.08.022  0.557
2017 Kim MW, Jeong HY, Kang SJ, Choi MJ, You YM, Im CS, Lee TS, Song IH, Lee CG, Rhee KJ, Lee YK, Park YS. Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles. Scientific Reports. 7: 9474. PMID 28842588 DOI: 10.1038/s41598-017-09555-w  0.398
2017 Hwang HS, Kim KH, Lee Y, Lee YT, Ko EJ, Park S, Lee JS, Lee BC, Kwon YM, Moore ML, Kang SM. Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats. Human Vaccines & Immunotherapeutics. 0. PMID 28129031 DOI: 10.1080/21645515.2016.1272743  0.525
2016 Ko EJ, Lee YT, Kim KH, Lee Y, Jung YJ, Kim MC, Lee YN, Kang T, Kang SM. Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine. Journal of Immunology (Baltimore, Md. : 1950). PMID 27881702 DOI: 10.4049/jimmunol.1600173  0.508
2016 Han SS, Yang SH, Choi M, Kim HR, Kim K, Lee S, Moon KC, Kim JY, Lee H, Lee JP, Jung JY, Kim S, Joo KW, Lim CS, Kang SW, et al. The Role of TNF Superfamily Member 13 in the Progression of IgA Nephropathy. Journal of the American Society of Nephrology : Jasn. PMID 27068226 DOI: 10.1681/Asn.2015060677  0.304
Show low-probability matches.